Authors
Vanessa Aitken, Anthony F T Moore, Manuel Terrazas-López, Salvador Rodarte, Eda Koculi
Published in
Frontiers in drug discovery. Volume 6. Epub Apr 13, 2026.
Abstract
The Zika virus (ZIKV) is an Orthoflavivirus linked to several neurological and developmental diseases, and it remains a significant global health concern for which no treatments or vaccines are currently available. In this study, we optimized the malachite green colorimetric assay, previously used to measure the RNA-dependent RNA polymerase (RdRp) activity of the hepatitis C and foot-and-mouth disease viruses, and applied this assay for the preliminary identification of the ZIKV RdRp modulators. RdRp is an enzyme essential for viral replication. Modulator screening was conducted using 204 compounds from the Natural Product Set IV of the National Cancer Institute Developmental Therapeutics Program. We identified two compounds, purpurogallin and digallic acid, as preliminary modulators of the ZIKV RdRp. Future studies will validate these preliminary hits using orthogonal assays, perform dose-response analyses, and elucidate their mechanisms of action.
PMID:
42577774
Bibliographic data and abstract were imported from PubMed on 15 Sep 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0